VEGFA and neoplasm: These EVs actively remodel the tumor microenvironment (TME) by reprogramming nearby astrocytes and microglia into tumor-supportive phenotypes, promoting immune evasion through T cell dysfunction and M2 macrophage polarization, and stimulating angiogenesis via pro-angiogenic cargo such as VEGF and miR-19b.